Search Within

Robert Sime Cimera

  1. "Maria Arcila"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (13)
  2. Center for Hematologic Malignancies (9)
  3. Department of Medicine (9)
  4. Graduate Medical Education (9)
  5. Hematologic Malignancies, Division of (9)
  6. Sloan Kettering Institute Postdocs (9)

More Groups

People
  1. Maria Arcila (13)
  2. Yanming Zhang (13)
  3. Alexander Lesokhin (6)
  4. Carlyn Rose Tan (6)
  5. Hani Hassoun (6)
  6. Kylee Maclachlan (6)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (1)
  4. 2018 (3)
Publications
  1. Blood (4)
  2. Clinical Lymphoma, Myeloma and Leukemia (3)
  3. Acta Neuropathologica (1)
  4. Blood Advances (1)
  5. Journal of Molecular Diagnostics (1)
  6. Journal of Neuropathology and Experimental Neurology (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (3)
  3. Elsevier Science, Inc. (1)
  4. Nature Publishing Group (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)
    Meeting Abstract

    Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Para-medullary (PMD) and extra-medullary (EMD) myeloma demonstrate increased copy number aberration, mutational burden, structural variants and genomic complexity compared to marrow-based myeloma
    Meeting Abstract

    Maclachlan, K.; GarceĢs, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Blaney, P.; Ziccheddu, B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
    Research Letter

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Reiner, A. S.; Cimera, R.; Nandakumar, S.; Price, A.; Vanderbilt, C.; Fahy, T.; Young, R. J.; more...
    Acta Neuropathologica (2023)

    Fulltext@MSK | Save
  • Allele-specific loss or mutations in CDKN2A/B worsen overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Allele-specific CDKN2A/B loss worsens overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Erythroid and megakaryocytic differentiation program in JAK2-mutated acute myeloid leukemia with or without antecedent myeloproliferative neoplasm
    Meeting Abstract

    Liu, Y.; Sethi, S.; Koche, R.; Gao, Q.; Dilip, D.; Glass, J. L.; Galera, P. K.; Persaud, S.; Mishra, T.; Sun, X.; more...
    Blood (2022)

    Fulltext@MSK | Save